Kenichiro Nishida
Overview
Explore the profile of Kenichiro Nishida including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
16
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Matsunaga K, Yoshida Y, Makita N, Nishida K, Rhodes K, Nordon C
Adv Ther
. 2024 Jul;
41(8):3362-3377.
PMID: 38976123
Introduction: Severe exacerbations of chronic obstructive pulmonary disease (COPD) are known to increase the risk of cardiovascular events. However, this association has not been investigated specifically in patients with COPD...
2.
Ueno M, Shirakawa S, Tokumaru J, Ogi M, Nishida K, Hirai T, et al.
J Hepatobiliary Pancreat Sci
. 2024 Jul;
31(7):468-480.
PMID: 38953871
Purpose: To describe the real-world treatment patterns of systemic therapies for biliary tract cancer (BTC) and to examine the frequency and management of biliary infection in Japan. Methods: Patients diagnosed...
3.
Harada N, Makita N, Fukui K, Nishida K, Oneda K, Tashiro N
J Asthma Allergy
. 2023 Jan;
16:83-93.
PMID: 36636701
Purpose: The disease burden of severe asthma patients stratified by type 2 (T2) biomarkers is not well studied in large patient samples, especially for T2-low severe asthma patients. Using a...
4.
Yabe D, Shiki K, Suzaki K, Meinicke T, Kotobuki Y, Nishida K, et al.
BMJ Open
. 2021 Apr;
11(4):e045844.
PMID: 33827843
Introduction: Elderly people (≥65 years) with type 2 diabetes mellitus (T2DM) are becoming increasingly prevalent, notably in Japan. As cardiovascular (CV) risk increases with age and sodium-glucose cotransporter-2 (SGLT2) inhibitors...